Chemokine Receptors in T-Cell-Mediated Diseases of the Skin

被引:30
|
作者
Lonsdorf, Anke S. [1 ]
Hwang, Sam T. [2 ]
Enk, Alexander H. [1 ]
机构
[1] Univ Heidelberg Hosp, Dept Dermatol, D-69115 Heidelberg, Germany
[2] Med Coll Wisconsin, Dept Dermatol, Milwaukee, WI 53226 USA
关键词
MACROPHAGE INFLAMMATORY PROTEIN-3-ALPHA/CCL20; ACTIVATION-REGULATED CHEMOKINE; CUTANEOUS LYMPHOCYTE ANTIGEN; ELEVATED SERUM CTACK/CCL27; ATOPIC-DERMATITIS; MYCOSIS-FUNGOIDES; CUTTING EDGE; DENDRITIC CELLS; EPIDERMAL HYPERPLASIA; IMMUNE SURVEILLANCE;
D O I
10.1038/jid.2009.122
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The chemokine/chemokine receptor network is an integral element of the complex system of homeostasis and immunosurveillance. Initially studied because of their role in coordinating tissue-specific migration and activation of leucocytes, chemokines have been implicated in the pathogenesis of various malignancies and diseases with strong inflammatory components. We discuss recent findings suggesting a critical involvement of chemokine receptor interactions in the immunopathogenesis of classical inflammatory skin disorders such as psoriasis and atopic dermatitis, as well as neoplastic diseases with a T-cell origin, such as mycosis fungoides. A deeper understanding of the underlying contribution of the chemokine network in the disease processes is key for the development of selective targeted immunotherapeutics that may meet the delicate balance between efficacy and safety.
引用
收藏
页码:2552 / 2566
页数:15
相关论文
共 50 条
  • [41] Molecular mechanism of T-cell-mediated suppression
    Cortesini, NSF
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (06) : 1998 - 1998
  • [42] Myocardial aging as a T-cell-mediated phenomenon
    Ramos, Gustavo Campos
    van den Berg, Anne
    Nunes-Silva, Vnia
    Weirather, Johannes
    Peters, Laura
    Burkard, Matthias
    Friedrich, Mike
    Pinnecker, Juergen
    Abesser, Marco
    Heinze, Katrin G.
    Schuh, Kai
    Beyersdorf, Niklas
    Kerkau, Thomas
    Demengeot, Jocelyne
    Frantz, Stefan
    Hofmann, Ulrich
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (12) : E2420 - E2429
  • [43] Costimulation of T-cell-mediated tumor immunity
    Hellstrom, KE
    Chen, LP
    Hellstrom, I
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1996, 38 : S40 - S41
  • [44] THE SENSITIZATION PHASE OF T-CELL-MEDIATED IMMUNITY
    STEINMAN, RM
    KOIDE, S
    WITMER, M
    CROWLEY, M
    BHARDWAJ, N
    FREUDENTHAL, P
    YOUNG, J
    INABA, K
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1988, 546 : 80 - 90
  • [45] γδ T-cell-mediated immune responses to malaria
    Bayarsaikhan, Ganchimeg
    Ibraheem, Yarob
    Inoue, Shin-Ichi
    MICROBIOLOGY AND IMMUNOLOGY, 2023, 67 (05) : 239 - 247
  • [46] REGULATION OF DEVELOPMENT OF T-CELL-MEDIATED CYTOTOXICITY
    VEIT, BC
    FEDERATION PROCEEDINGS, 1978, 37 (06) : 1683 - 1683
  • [47] ROLE OF OXYGEN IN T-CELL-MEDIATED CYTOLYSIS
    NATHAN, CF
    MERCERSMITH, JA
    DESANTIS, NM
    PALLADINO, MA
    JOURNAL OF IMMUNOLOGY, 1982, 129 (05): : 2164 - 2171
  • [48] Molecular phenotyping of T-cell-mediated rejection
    Chong, Anita S.
    Perkins, David L.
    NATURE REVIEWS NEPHROLOGY, 2014, 10 (12) : 679 - 680
  • [49] Redox Imbalance in T Cell-Mediated Skin Diseases
    Pastore, Saveria
    Korkina, Liudmila
    MEDIATORS OF INFLAMMATION, 2010, 2010
  • [50] Psoriasis: A T-cell-mediated disease? Reply
    Valdimarsson, H
    IMMUNOLOGY TODAY, 1996, 17 (01): : 46 - 47